UnitedHealth (NYSE: UNH) shares Q4 and full-year 2025 results

Rhea-AI Filing Summary

UnitedHealth Group Incorporated furnished a current report announcing that it has issued a press release with its fourth quarter and full year 2025 results. The press release is provided as Exhibit 99.1, and a hyperlinked PDF version is provided as Exhibit 99.2, both incorporated by reference in this report. The company also notes that the information under the results section is being furnished, not filed, so it is not automatically subject to certain liability provisions or incorporated into other securities law filings unless specifically referenced.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000731766false00007317662026-01-272026-01-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

—————————————

FORM 8-K

—————————————

Current Report

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 27, 2026

—————————————

UNITEDHEALTH GROUP INCORPORATED

(Exact name of registrant as specified in its charter)

—————————————

Delaware

1-10864

41-1321939

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1 Health Drive

655 New York Avenue NW

Eden Prairie,

Minnesota

55344

Washington,

DC

20001

(Address of principal executive offices)

(Zip Code)

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (800) 328-5979

N/A

(Former name or former address, if changed since last report.)

—————————————

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.01 par value

UNH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02    Results of Operations and Financial Condition.

On January 27, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference.

The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.    Financial Statements and Exhibits.

Exhibit

Description

99.1

Press Release dated January 27, 2026

99.2

Hyperlinked PDF

104

Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 27, 2026                 

UNITEDHEALTH GROUP INCORPORATED

By:

/s/ Kuai H. Leong

Kuai H. Leong

Senior Deputy General Counsel and Deputy Corporate Secretary

FAQ

What did UnitedHealth Group (UNH) disclose in this 8-K?

UnitedHealth Group (UNH) disclosed that it issued a press release announcing its fourth quarter and full year 2025 results, which is furnished as Exhibit 99.1 along with a hyperlinked PDF as Exhibit 99.2.

Where can investors find UnitedHealth Group’s Q4 and 2025 results?

Investors can find UnitedHealth Group’s Q4 and 2025 results in the press release furnished as Exhibit 99.1 and in the hyperlinked PDF furnished as Exhibit 99.2 to this report.

Are UnitedHealth Group’s Q4 and 2025 results considered filed with the SEC?

The company states that the information in the results section of this report is furnished, not filed, so it is not deemed filed under Section 18 of the Exchange Act or automatically incorporated into other filings unless specifically referenced.

What exhibits are included with UnitedHealth Group’s 8-K for Q4 and 2025 results?

The report includes Exhibit 99.1 (press release dated January 27, 2026), Exhibit 99.2 (hyperlinked PDF of the release), and Exhibit 104 (cover page interactive data file in Inline XBRL format).

Who signed UnitedHealth Group’s 8-K covering the Q4 and 2025 results?

The report was signed on behalf of UnitedHealth Group Incorporated by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary.